<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">34851466</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>04</Month>
        <Day>15</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>04</Month>
        <Day>15</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1435-702X</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>260</Volume>
            <Issue>5</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>May</Month>
            </PubDate>
          </JournalIssue>
          <Title>Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie</Title>
          <ISOAbbreviation>Graefes Arch Clin Exp Ophthalmol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Decreased Bell's phenomenon after inferior and medial orbital wall decompression in thyroid-associated ophthalmopathy: a double-edged sword in management of the patients.</ArticleTitle>
        <Pagination>
          <StartPage>1701</StartPage>
          <EndPage>1705</EndPage>
          <MedlinePgn>1701-1705</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1007/s00417-021-05509-1</ELocationID>
        <Abstract>
          <AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">To evaluate the changes in Bell's phenomenon after inferior and medial orbital wall decompression in patients with thyroid-associated ophthalmopathy (TAO).</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">This prospective interventional study included patients with moderate to severe non-active TAO, who underwent inferior and medial wall orbital decompression. Bell's phenomenon and adjusted Bell's phenomenon were evaluated at baseline and six months after surgery. Bell's phenomenon was assessed by holding the upper lid open during forced eyelid closure. Afterwards, the upward excursion, the distance between lower eyelid margin and lower corneal limbus, was measured. Adjusted Bell's phenomenon distance is defined as the difference between margin reflex distance two (MRD2) and Bell's phenomenon distance.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">Thirty TAO patients, including 15 males (50%), with a mean age of 43.6 ± 11.6 years, were enrolled. The distance of Bell's phenomenon significantly decreased after surgery by an average of 3.25 ± 1.57 mm (P &lt; 0.001). In addition, the difference between pre- and post-operative distance of adjusted Bell's phenomenon was - 1.58 ± 2.13 (P &lt; 0.001) corresponding to the worsening in the adjusted Bell's phenomenon.</AbstractText>
          <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The result of our study demonstrated that Bell's phenomenon decreases significantly after inferior and medial wall decompression, which could be considered a complication of this form of orbital wall decompression in TAO.</AbstractText>
          <CopyrightInformation>© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Eshraghi</LastName>
            <ForeName>Bahram</ForeName>
            <Initials>B</Initials>
            <AffiliationInfo>
              <Affiliation>Isfahan Eye Research Center, Department of Ophthalmology, Isfahan University of Medical Sciences, Isfahan, Iran.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Moayeri</LastName>
            <ForeName>Maryam</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Eye Research Center, Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, Iran. Moayeri_maryam@yahoo.com.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Pourazizi</LastName>
            <ForeName>Mohsen</ForeName>
            <Initials>M</Initials>
            <Identifier Source="ORCID">0000-0002-9714-8209</Identifier>
            <AffiliationInfo>
              <Affiliation>Isfahan Eye Research Center, Department of Ophthalmology, Isfahan University of Medical Sciences, Isfahan, Iran.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Rajabi</LastName>
            <ForeName>Mohammad Taher</ForeName>
            <Initials>MT</Initials>
            <AffiliationInfo>
              <Affiliation>Eye Research Center, Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, Iran.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Rafizadeh</LastName>
            <ForeName>Mohsen</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Eye Research Center, Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, Iran. Mohsen_Raf1354@yahoo.com.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2021</Year>
          <Month>12</Month>
          <Day>01</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Germany</Country>
        <MedlineTA>Graefes Arch Clin Exp Ophthalmol</MedlineTA>
        <NlmUniqueID>8205248</NlmUniqueID>
        <ISSNLinking>0721-832X</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D019299" MajorTopicYN="N">Decompression, Surgical</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D049970" MajorTopicYN="Y">Graves Ophthalmopathy</DescriptorName>
          <QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
          <QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
          <QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009915" MajorTopicYN="N">Orbit</DescriptorName>
          <QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Bell’s phenomenon</Keyword>
        <Keyword MajorTopicYN="N">Graves</Keyword>
        <Keyword MajorTopicYN="N">Ophthalmopathy</Keyword>
        <Keyword MajorTopicYN="N">Orbital wall decompression</Keyword>
        <Keyword MajorTopicYN="N">Thyroid-associated ophthalmopathy</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2021</Year>
          <Month>5</Month>
          <Day>17</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2021</Year>
          <Month>11</Month>
          <Day>24</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2021</Year>
          <Month>11</Month>
          <Day>17</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2021</Year>
          <Month>12</Month>
          <Day>2</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>16</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2021</Year>
          <Month>12</Month>
          <Day>1</Day>
          <Hour>12</Hour>
          <Minute>31</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">34851466</ArticleId>
        <ArticleId IdType="doi">10.1007/s00417-021-05509-1</ArticleId>
        <ArticleId IdType="pii">10.1007/s00417-021-05509-1</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Muñoz-Ortiz J, Sierra-Cote MC, Zapata-Bravo E et al (2020) Prevalence of hyperthyroidism, hypothyroidism, and euthyroidism in thyroid eye disease: a systematic review of the literature. Syst Rev 9(1):201</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s13643-020-01459-7</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Antonelli A, Fallahi P, Elia G et al (2020) Graves’ disease: Clinical manifestations, immune pathogenesis (cytokines and chemokines) and therapy. Best Pract Res Clin Endocrinol Metab 34(1):101388</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.beem.2020.101388</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Akbari M, Bayat R, Mirmohammadsadeghi A et al (2020) Strabismus surgery in thyroid-associated ophthalmopathy; surgical outcomes and surgical dose responses. J Binocul Vis Ocul Motil 70(4):150–156</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1080/2576117X.2020.1792029</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Łacheta D, Miśkiewicz P, Głuszko A et al (2019) Immunological Aspects of Graves’ Ophthalmopathy. Biomed Res Int 2019:7453260</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1155/2019/7453260</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Khatavi F, Nasrollahi K, Zandi A et al (2017) A promising modified procedure for upper eyelid retraction-associated Graves’ ophthalmopathy: transconjunctival lateral levator aponeurectomy. Med Hypothesis Discov Innov Ophthalmol 6(2):44–48</Citation>
        </Reference>
        <Reference>
          <Citation>Takahashi Y, Sabundayo MS, Mito H et al (2017) Bell’s phenomenon in thyroidassociated inferior rectus myopathy. Graefes Arch Clin Exp Ophthalmol 255(12):2467–2471</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00417-017-3792-9</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kj A, Sadeghi-Tari A, Minaee-Noshahr N et al (2010) Ocular movement disorders and extraocular muscle involvement in Iranian Graves’ ophthalmopathy patients. Binocul Vis Strabismus Q 25(4):217–230</Citation>
        </Reference>
        <Reference>
          <Citation>Fraco I, Doba J (1984) Bell’s phenomenon: a study of 508. Aust J Ophthalmol 12(1):15–21</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1442-9071.1984.tb01119.x</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fichter N, Guthoff RF, Schittkowski MP. (2012) Orbital decompression in thyroid eye disease. ISRN Ophthalmol 2012:739236.</Citation>
        </Reference>
        <Reference>
          <Citation>Ediriwickrema LS, Korn BS, Kikkawa DO (2018) Orbital decompression for thyroid-related orbitopathy during the quiescent phase. Ophthalmic Plast Reconstr Surg 34:90–97</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/IOP.0000000000001119</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Park HH, Chun YS, Moon NJ et al (2018) Change in eyelid parameters after orbital decompression in thyroid-associated orbitopathy. Eye (Lond) 32(6):1036–1041</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41433-018-0022-6</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sakata K-i, Hareyama M, Oouchi A et al (1998) Radiotherapy in the management of Graves’ ophthalmopathy. Jpn J Clin Oncol 28(6):364–367</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/jjco/28.6.364</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Choi SW, Lee JY, Lew H (2016) Customized orbital decompression surgery combined with eyelid surgery or strabismus surgery in mild to moderate thyroid-associated ophthalmopathy. Korean J Ophthalmol 30(1):1–9</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3341/kjo.2016.30.1.1</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ben Simon GJ, Mansury AM, Schwarcz RM et al (2005) Simultaneous orbital decompression and correction of upper eyelid retraction versus staged procedures in thyroid-related orbitopathy. Ophthalmology 112(5):923–932</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ophtha.2004.12.028</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Paridaens DA, Verhoeff K, Bouwens D et al (2000) Transconjunctival orbital decompression in Graves’ ophthalmopathy: lateral wall approach ab interno. Br J Ophthalmol 84(7):775–781</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/bjo.84.7.775</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hill RH, Czyz CN, Bersani TA (2012) Transcaruncular medial wall orbital decompression: an effective apprcoach for patients with unilateral graves ophthalmopathy. ScientificWorldJournal 2012:312361</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1100/2012/312361</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Miyata K, Amano S, Sawa M et al (2003) A novel grading method for superficial punctate keratopathy magnitude and its correlation with corneal epithelial permeability. Arch Ophthalmol 121(11):1537–1539</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1001/archopht.121.11.1537</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
